Biochemical Assay Development: Strategies to Speed Up Research

Summary

Biochemical assay development is the process of designing, optimizing, and validating methods to measure enzyme activity, binding, or functional outcomes. It’s a cornerstone of preclinical research—enabling scientists to screen compounds, study mechanisms, and evaluate drug candidates. By combining proven universal assay platforms such as Transcreener® and AptaFluor®, with sound assay optimization strategies, researchers can dramatically accelerate biochemical research—saving time, reducing cost, and ensuring data quality.

In vitro biochemical assay development can be a long and expensive process, consuming months and thousands of dollars.¹ Finding an off-the-shelf solution that’s been proven in drug discovery can help remove some of the painstaking labor required for enzymatic assay development.

While a wide range of biochemical assays for high-throughput screening are commercially available, each assay method is unique. Some have been developed for individual targets, while others can be used with a broader assortment.

Universal activity assays can help simplify the process as researchers work on multiple targets within an enzyme family. These assays work by detecting a product of an enzymatic reaction common between various targets. One example is studying a variety of kinase targets with the same universal ADP assay.

Universal activity assays detect the products produced by the enzyme allowing multiple targets to be studied with the same assay. Above is the fundamental assay concept for the Transcreener platform. Using competitive direct detection with various antibody and tracer modifications provides multiple fluorescent formats such as FI, FP, and TR-FRET. 

---

The Importance of Biochemical Assay Development

Assays are the tools that translate biological phenomena into measurable data. In drug discovery, a well-designed biochemical assay can distinguish a promising hit from a false positive, or reveal the kinetic behavior of a new inhibitor. Without reliable assays, even the best compound libraries and screening systems fall short.

The biochemical assay development process links fundamental enzymology with translational discovery. It defines how enzyme function is quantified, how inhibitors are ranked, and how selectivity and mechanism are understood. Effective assay development minimizes variability, enhances throughput, and ensures reproducible, interpretable data.

However, traditional assay development can be long and expensive. Designing a fit-for-purpose assay may take months, with iterative optimization cycles for substrates, buffers, and readouts. That’s why universal assay technologies—like those pioneered by BellBrook Labs—have become critical for speeding up research.

A Universal Biochemical Assay Provides Options

Sometimes universal assays are the only commercially available option for challenging targets. And since they measure the products of an enzymatic reaction, it’s easy to determine enzymatic activity. This information allows the scientist to learn how a compound modulates the target protein’s enzymatic properties. Popular data points include IC₅₀ or EC₅₀, both of which can be determined quickly to accelerate SAR.

Some assays like Transcreener were designed with a simple mix-and-read format. Once the concentration of detection reagents is established just run the enzyme reaction, add the detection reagents, and read the plate. This configuration is amenable to high throughput screening. Fewer steps help simplify automation and produce robust results.

Mix-and-read assays are great for HTS and lead discovery due to their simple yet robust nature. After the enzyme reaction is complete, add the detection reagents, incubate, and read the plate.

Understanding the Assay Development Process

Every biochemical assay development project follows a structured sequence of steps, balancing precision with practicality:

1. Define the biological objective.
   Identify the enzyme or target, understand its reaction type (kinase, glycosyltransferase, PDE, PARP, etc.), and clarify what functional outcome must be measured—product formation, substrate consumption, or binding event.

2. Select the detection method.
   Choose a detection chemistry compatible with your target’s enzymatic product—fluorescence intensity (FI), fluorescence polarization (FP), time-resolved FRET (TR-FRET), or luminescence. The decision depends on sensitivity, dynamic range, and instrument availability.

3. Develop and optimize assay components.
   Determine optimal substrate concentration, buffer composition, enzyme and cofactor levels, and detection reagent ratios. This is where custom assay development expertise often matters most.

4. Validate assay performance.
   Evaluate key metrics such as signal-to-background ratio, coefficient of variation (CV), and Z′-factor. A Z′ > 0.5 typically indicates robustness suitable for high-throughput screening (HTS).

5. Scale and automate.
   Once validated, the assay is miniaturized (e.g., 384- or 1536-well plates) and adapted to automated liquid handlers to support screening or profiling.

6. Data interpretation and follow-up.
   Assay results inform structure–activity relationships (SAR), mechanism of action (MOA) studies, and orthogonal confirmatory assays.

These assay development steps create a foundation for reproducibility and scalability—essential qualities in modern discovery workflows.

Achieving Assay Success

Once an assay has been used, it becomes inherently familiar to the scientist. This familiarity can make it easier to develop assays for other targets at a much more rapid pace. There will always be small modifications based on the target, buffer conditions, and substrate. If the assay system is robust, adapting new targets to the system can be done with limited development.

Assay validation can be challenging, knowing the expected characteristics for robust data such as Z’ can simplify. Although there is always some method validation required prior to any screen, HTS ready biochemical assays for enzyme targets can help mitigate poor assay performance. This moves thoughts from “Is my assay working?” to “What is the data telling me?”

Instrumentation is also critical to assay success. Once a universal platform has been introduced, the correct instrument settings have been determined. Understanding a plate reader, using the right assay plate, and familiarity how an assay’s readout is achieved are all critical factors to the project. Once settings are optimized for speed and accuracy, the same configuration can be used for new targets and thus simplifying future development.

 

---

Techniques in Biochemical Assay Development

Biochemical assay development encompasses a variety of techniques designed to measure molecular function, enzyme activity, or binding interactions in a controlled in vitro environment. The choice of technique depends on the biological target, detection requirements, and throughput needs.

1. Binding Assays

Binding assays quantify molecular interactions such as protein–ligand, receptor–inhibitor, or protein–nucleic acid binding.
They are typically used to measure affinity (Kd), dissociation rates (koff), or competitive displacement between molecules.

Common techniques include:

• Fluorescence Polarization (FP): Detects changes in rotational diffusion when a fluorescent ligand binds a larger protein.
• Surface Plasmon Resonance (SPR): Measures real-time association/dissociation without labeling.
• FRET- or TR-FRET-based binding assays: Rely on energy transfer between fluorophores in proximity, providing a sensitive readout for binding events.

Binding assays are particularly valuable in early discovery for hit validation and selectivity profiling, complementing enzymatic assays.

2. Enzymatic Activity Assays

Enzymatic assays form the core of biochemical assay development, as they directly measure the functional outcome of an enzyme-catalyzed reaction. They determine how substrates are converted to products and how this activity is modulated by compounds.

Techniques can be divided into two main categories:

a. Coupled or Indirect Enzymatic Assays

These rely on a secondary enzyme system to convert the product of interest into a detectable signal.
Example: Measuring kinase activity by coupling ADP production to a luciferase reaction that generates luminescence.

Advantages: Can provide signal amplification and use well-established reagents.
Limitations: Each coupling step introduces potential sources of interference or variability.

b. Direct Detection Assays

Homogeneous “mix-and-read” assays simplify workflows by directly detecting enzymatic products without coupling reactions or separation steps.

Examples:

• The Transcreener ADP² Kinase Assay directly measures ADP formation from ATP using competitive immunodetection.
• The AptaFluor SAH Methyltransferase Assay uses aptamer-based TR-FRET to quantify S-adenosylhomocysteine (SAH) from methyltransferase reactions.

Advantages:

• Fewer steps reduce variability and increase throughput.
• Universal product detection enables broad applicability across enzyme classes (kinases, ATPases, GTPases, methyltransferases, etc.).
• Compatible with multiple readouts (FI, FP, TR-FRET), offering flexibility for diverse instruments and workflows.

Because they are cell-free, homogeneous enzymatic assays are inherently well-suited for high-throughput screening (HTS)—providing quantitative, reproducible data ideal for early drug discovery.

3. Specialty Biochemical Assay Formats

Beyond the primary categories, researchers may use specialized techniques depending on their experimental goals:

• Kinetic assays measure real-time reaction rates rather than endpoint product formation.
• Radiometric assays offer high sensitivity by tracking labeled substrates or products (though increasingly replaced by fluorescence-based methods).
• Label-free detection (e.g., calorimetry or mass spectrometry) enables direct measurement of molecular changes without dyes or antibodies.

These specialized methods often serve as orthogonal confirmation assays—providing complementary validation alongside primary screening formats like Transcreener or AptaFluor.

Summary

In practice, most biochemical assay development projects combine multiple techniques:

• Binding assays to confirm molecular interactions, and
• Enzymatic assays—either coupled or homogeneous—to measure function and inhibitor potency.

By selecting the right detection chemistry and optimizing conditions for sensitivity and reproducibility, researchers can accelerate discovery while maintaining data quality.

Optimization Strategies for Robust Assays

Optimization is the most iterative and technical phase of biochemical assay development. Key strategies include:

1. Fine-Tune Reagent Concentrations – Achieve a balance between sensitivity and cost by titrating enzyme and substrate concentrations.
2. Buffer Composition and pH – Optimize ionic strength, cofactors, and additives to stabilize enzyme activity.
3. Signal-to-Background and Dynamic Range – Adjust detection reagent ratios or incubation times for best performance.
4. Control Experiments – Always include enzyme-free and substrate-free controls.
5. Statistical Validation – Use the Z′-factor as a quality benchmark.

Instrumentation and Validation Considerations

A reliable biochemical assay depends not only on chemistry but also on instrumentation. Proper plate reader configuration ensures accuracy and reproducibility. Choose the right plate, calibrate excitation/emission settings, and standardize read modes. Once validated, these parameters can be reused for new targets—simplifying future development.

Simplify Biochemical Assay Development and Follow-Up Studies

As new assay techniques are introduced commercially, technology affords the opportunity to accelerate drug discovery and save time in the early stages of hit-to-lead. Biochemical assays can then be used in follow up studies, including MOA, and SAR, making the assay a multi-tool of drug discovery.

An assay with a proven track record can eliminate much of the development process by providing an out-of-the-box solution. So when looking to accelerate your biochemical assay development, consider proven universal assay kits. Many can be used for your protein target of interest, and provide a robust but straightforward option.

Biochemical assay development remains the backbone of modern drug discovery. From basic enzymology to industrial-scale HTS, every successful screening campaign starts with a reliable assay. By mastering the assay development process, employing universal platforms, and applying rigorous optimization strategies, scientists can transform slow trial-and-error workflows into streamlined, data-rich pipelines.

BellBrook Labs’ Transcreener and AptaFluor technologies exemplify how proven universal assays can simplify biochemical research—empowering teams to focus less on assay construction and more on insight generation.

Looking for some help. BellBrook Labs offers Assay Development Services to accelerate your drug discovery program.

FAQs

What are the techniques of assay development?

Techniques include binding assays, enzymatic activity assays, and homogeneous mix-and-read formats that measure molecular interactions or reaction products.

How to optimize an assay?

Optimization involves adjusting reagent concentrations, buffer conditions, and detection parameters to maximize signal-to-background, reproducibility, and Z′-factor.

What are the techniques used in biochemical assay development?

Common techniques include fluorescence polarization, TR-FRET, luminescence, colorimetric readouts, and aptamer-based detection. Each offers unique strengths for different enzyme classes.

What are the 4 types of assays?

Broadly, assays fall into four categories: biochemical, cell-based, binding, and functional. Biochemical assays measure direct molecular activity. A functional assay is a broad term encompassing any assay that measures biological activity — including biochemical or cellular readouts — but usually used in contrast to binding-only assays. Its purpose is to determine biological function or effect, rather than just molecular interaction. Functional assays measure “what the molecule does,” not just “whether it binds.”

What are the methods of assaying?

Methods include endpoint and kinetic measurements, direct product detection, coupled enzyme systems, and competition-based formats.

References

1. Assay Guidance Manual [Internet]. Sittampalam GS, Coussens NP, Brimacombe K, et al., editors. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-2019.
2. Principles of early drug discovery JP Hughes, S Rees, SB Kalindjian, KL Philpott Br J Pharmacol. 2011 Mar; 162(6): 1239–1249. doi: 10.1111/j.1476-5381.2010.01127.x